# Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

> **NCT00177008** · PHASE4 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 18 (—)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Social Anxiety Disorder

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00177008
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 18 (—)
- **Last updated:** 2007-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177008, "Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety". Retrieved via MORVS 2026-10-26 from https://api.morvs.ai/clinical/NCT00177008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*